Literature DB >> 22800863

CD24 regulates cell proliferation and transforming growth factor β-induced epithelial to mesenchymal transition through modulation of integrin β1 stability.

Kyung-min Lee1, Ji-hyun Ju, Kibeom Jang, Wonseok Yang, Jae Youn Yi, Dong Young Noh, Incheol Shin.   

Abstract

To determine the role of CD24 in breast cancer cells, we knocked down CD24 in MCF-7 human breast cancer cells by retroviral delivery of shRNA. MCF-7 cells with knocked down CD24 (MCF-7 hCD24 shRNA) exhibited decreased cell proliferation and cell adhesion as compared to control MCF-7 mCD24 shRNA cells. Decreased proliferation of MCF-7 hCD24 shRNA cells resulted from the inhibition of cell cycle progression from G1 to S phase. The specific inhibition of MEK/ERK signaling by CD24 ablation might be responsible for the inhibition of cell proliferation. Phosphorylation of Src/FAK and TGF-β1-mediated epithelial to mesenchymal transition was also down-regulated in MCF-7 hCD24 shRNA cells. Reduced Src/FAK activity was caused by a decrease in integrin β1 bound with CD24 and subsequent destabilization of integrin β1. Our results suggest that down-regulation of Raf/MEK/ERK signaling via Src/FAK may be dependent on integrin β1 function and that this mechanism is largely responsible for the CD24 ablation-induced decreases in cell proliferation and epithelial to mesenchymal transition.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22800863     DOI: 10.1016/j.cellsig.2012.07.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  12 in total

1.  Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.

Authors:  J Tang; H Cai; L Lin; P Xie; W Zhong; M Tang
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

2.  Role of CD24 in anoikis resistance of ovarian cancer cells.

Authors:  Yan-Hui Li; Xiang Sun; Hong-Bo Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

3.  Elevated hippocampal CD24 in astrocytes participates in neural regeneration possibly via activating SHP2/ERK pathway after experimental traumatic brain injury in mice.

Authors:  Xuan Gao; Han Wang; Yong-Yue Gao; Xiao-Ming Zhou; Tao Tao; Guang-Jie Liu; Yan Zhou; Wei Li; Chun-Hua Hang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.

Authors:  Jason E Duex; Charles Owens; Ana Chauca-Diaz; Garrett M Dancik; Lauren A Vanderlinden; Debashis Ghosh; Mariah Z Leivo; Donna E Hansel; Dan Theodorescu
Journal:  Cancer Res       Date:  2017-07-03       Impact factor: 12.701

5.  GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.

Authors:  Neeraj Agarwal; Garrett M Dancik; Andrew Goodspeed; James C Costello; Charles Owens; Jason E Duex; Dan Theodorescu
Journal:  Cancer Res       Date:  2016-06-16       Impact factor: 12.701

6.  CD24 tracks divergent pluripotent states in mouse and human cells.

Authors:  Nika Shakiba; Carl A White; Yonatan Y Lipsitz; Ayako Yachie-Kinoshita; Peter D Tonge; Samer M I Hussein; Mira C Puri; Judith Elbaz; James Morrissey-Scoot; Mira Li; Javier Munoz; Marco Benevento; Ian M Rogers; Jacob H Hanna; Albert J R Heck; Bernd Wollscheid; Andras Nagy; Peter W Zandstra
Journal:  Nat Commun       Date:  2015-06-16       Impact factor: 14.919

7.  CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.

Authors:  Tomohito Tanaka; Yoshito Terai; Yuhei Kogata; Keisuke Ashihara; Kazuya Maeda; Satoe Fujiwara; Saha Yoo; Yoshimichi Tanaka; Satoshi Tsunetoh; Hiroshi Sasaki; Masanori Kanemura; Akiko Tanabe; Masahide Ohmichi
Journal:  Oncol Rep       Date:  2015-09-08       Impact factor: 3.906

8.  CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.

Authors:  Kiyoko Nakamura; Yoshito Terai; Akiko Tanabe; Yoshihiro J Ono; Masami Hayashi; Kazuya Maeda; Satoe Fujiwara; Keisuke Ashihara; Michihiko Nakamura; Yoshimichi Tanaka; Tomohito Tanaka; Satoshi Tsunetoh; Hiroshi Sasaki; Masahide Ohmichi
Journal:  Oncol Rep       Date:  2017-04-19       Impact factor: 3.906

9.  Behavioral Characterizing of CD24 Knockout Mouse-Cognitive and Emotional Alternations.

Authors:  Keren Nitzan; Roni Toledano; Shiran Shapira; Nadir Arber; Ravid Doron
Journal:  J Pers Med       Date:  2021-02-06

10.  Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells.

Authors:  Dong-Jin Ye; Yeo-Jung Kwon; Sangyun Shin; Hyoung-Seok Baek; Dong-Won Shin; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.